NASDAQ
Editas Medicine, Inc. (EDIT) reported revenue of $40.52M and net income of $-160,060,000 for FY 2025, with a net profit margin of -395.0%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.